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GUT MUCOSAL ISCHEMIA 
.DURING NORMOTHERMIC 
CARDIOPULMONARY 
BYPASS RESULTS FROM 
BLOOD FLOW 
REDISTRIBUTION AND 
INCREASED OXYGEN 
DEMAND 
Impaired gut mucosal perfusion has been reported during cardiopulmonary 
bypass. To better define the adequacy of gut blood flow and oxygenation during 
cardiopulmonary b pass, we measured overall gut blood flow and ileal mucosal 
flow and their relationship to mucosal pH, mesenteric oxygen delivery and 
oxygen consumption in immature pigs (n = 8). Normothermic, noncross- 
clamped, right atrium-to-aorta c rdiopulmonary b pass was maintained at 
100 ml/kg per minute for 120 minutes. Animals were instrumented with an 
ultrasonic Doppler flow probe on the superior mesenteric artery, a mucosal 
laser Doppler flow probe in the ileum, and pH tonometers in the stomach, 
ileum, and rectum. Radioactive microspheres were injected before and at 5, 60, 
and 120 minutes of cardiopulmonary b pass for tissue blood flow measure- 
ments. Overall gut blood flow siguificantly increased uring cardiopulmonary 
bypass as evidenced by increases in superior mesenteric arterial flow to 134.1% 
_ 8.0%, 137.1% ± 7.5%, 130.3% _ 11.2%, and 130.2% - 12.7% of baseline 
values at 30, 60, 90, and 120 minutes of bypass, respectively. Conversely, ileal 
mucosal blood flow significantly decreased to 53.6% _ 6.4%, 49.5% + 6.8%, 
58.9% ± 11.6%, and 47.8% ± 10.0% of baseline values, respectively. Blood flow 
measured with microspheres was siguificantly increased to proximal portions 
of the gut, duodenum änd jejunum, during cardiopulmonary b pass, whereas 
blood flow to distal portions, ileum and colon, was unchanged. Gut mucosal pH 
decreased progressively during cardiopulmonary b pass and paralleled the 
decrease in ileal mucosal blood flow. Mesenteric oxygen delivery decreased 
significantly from 67.0 ± 10.0 ml/min per square meter at baseline to 42.4 ± 
4.6, 44.9 ± 3.5, 46.0 _ 3.6, and 42.9 -+ 3.9 ml/min per square meter at 30, 60, 
90, and 120 minutes of bypass. Despite he decrease in mesenteric oxygen 
delivery, mesenteric oxygen consumption i creased progressively from 10.8 ± 
1.4 ml/min per square meter at baseline to 13.4 ± 1.2, 15.9 ± 1.2, 16.7 ± 1.4, 
and 16.6 ± 1.54 ml/min per square meter, respectively. We conclude that gut 
mucosal ischemia during normothermic cardiopulmonary b pass results from 
a combination of redistribution of blood flow away from mucosa nd an 
increased oxygen demand. (J THORAC CARDIOVASC SURG 1995;110:819-28) 
Weike Tao, MD, a Joseph B. Zwischenberger, MD, a Thuan T. Nguyen, MD, a 
Roger A. Vertrees, CCP, a Laura B. McDaniel, MD, b Leta K. Nutt, BS, b 
David N. Herndon, MD, a and George C. Kramer, PhD, b Galveston, Tex. 
D espite advances in cardiopulmonary bypass 
(CPB) management, patients undergoing CPB 
are at risk for the development of postperfusion 
From the Departments of Surgery a and Anesthesiology, b Univer- 
sity of Texas Medical Branch, Galveston, Tex. 
Supported in part by a grant from the American He rt Associa- 
tion (92G-621). 
Presented at the Surgical Infection Society Fourteenth Annual 
Meeting, April 27-31, 1994, Toronto, Ontario, Canada. 
Received for publication Sept. 2, 1994. 
Accepted for publication Dec. 22, 1994. 
Address for reprints: Joseph B. Zwischenberger, MD, Cardiotho- 
racic Surgery, University of Texas Medical Branch, Galveston, 
TX 77555-0528. 
systemic inflammatory response syndrome and mul- 
tiorgan dysfunction syndrome. In their most pro- 
nounced forms, systemic inflammatory response 
syndrome and multiorgan dysfunction syndrome 
may be manifested as pulmonary, renal, and gastro- 
intestinal tract dysfunction and hemodynamic nsta- 
bility in the postoperative period. 1 The initiation of 
these responses is often attributed to whole-body 
inflammatory reactions caused by extensive blood- 
surface interactions, z activation of the complement 
system and polymorphonuclear leukocytes, 3' 4 oxy- 
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gen free-radical generation, 5 and release of cyto- 
kines.6, 7
Recently, the development of systemic inflamma- 
tory response syndrome and multiorgan dysfunction 
syndrome in critically ill patients has been attributed 
to pathophysiologic changes in the gut. s Gut isch- 
emia can jeopardize the integrity of the mucosal 
barrier and increase the prevalence of bacterial 
translocation and endotoxin absorption from the 
gut.9, 10 Meanwhile, impaired mucosal perfusion has 
been reported uring experimental nd clinical CPB 
with the use of laser Doppler flowmetry. 11-14 Fid- 
dian-Green and Baker, a5 with use of gastrointestinal 
tract tonometers to show a decrease in gastric 
mucosal pH, an indicator of gut mucosal ischemia, 
positively correlated gastric mucosal hypoperfusion 
with increased infections and gastrointestinal tract 
complications after cardiac operations. In contrast, 
early work on regional perfusion during extracorpo- 
real circulation with the venous outflow 16 and mi- 
crosphere ~7 techniques showed an increase in blood 
flow to the gut in canine and primate models, yet gut 
oxygen consumption (V02) was decreased in the 
canine model, suggesting shunting of blood flow 
away from the metabolically active gut mucosa. 
Changes in gut organ blood flow and V02 during 
CPB have not been quantitatively defined. Hypo- 
thermic CPB has been shown to cause an initial 
decrease in gut V02 followed by a subsequent in- 
crease with rewarming. 13 The relationship between 
total gut or mucosal blood flow and gut metabolism 
is important in understanding the mechanism of 
postperfusion systemic inflammatory response syn- 
drome and multiorgan dysfunction syndrome and in 
seeking efforts to reduce the associated morbidity 
and mortality. In the present study, we investigated 
the effects of normothermic CPB on total mesen- 
teric blood flow, fractional blood flow to different 
regions of the gut, gut mucosal pH, and mucosal 
blood flow and their relationship to gut Vo 2. 
Material and methods 
The experimental protocol was approved by the Animal 
Care and Use Committee of the University of Texas 
Medical Branch, Gälveston, Tex. All animals received 
humane care in compliance with the "Principles of Lab- 
oratory Animal Care" formulated by the National Society 
for Medical Research and the "Guide for the Care and 
Use of Laboratory Animals" prepared by the Institute of 
Laboratory Animal Resources and published by the Na- 
tional Institutes of Health (NIH Publication No. 86-23, 
revised 1985). 
Studies were done in eight female immature Yorkshire 
pigs weighing 25.6 + 4.3 kg. After an overnight fast, pigs 
were sedated with intramuscular ketamine (7.5 mg/kg) 
and the lungs mechanically ventilated with 2.0% to 2.5% 
isoflurane after endotracheal intubation. The pigs were 
then instrumented with femoral arterial and venous cath- 
eters and a pulmonary arterial catheter with an on-line 02 
saturation probe tip (Opticath, Abbott, Mountain View, 
Calif.). A left flank incision allowed retroperitoneal expo- 
sure of the superior mesenteric artery (SMA) and a 
transit-time ultrasonic flow probe (Transonic, Ithaca, 
N.Y.) was placed on the vessel at its origin from the 
abdominal aorta. Through the same incision, intraperito- 
neally, a purse-string suture was made on a tributary 
mesenteric vein through which an infant feeding catheter 
was placed at a length of 15 to 20 cm to reach the portal 
vein for retrieval of blood samples. A laser Doppler flow 
probe (LDF 1000, Transonic) was placed directly on the 
ileal mucosa via an antimesenteric enterotomy with the 
laser sensor secured facing the mucosa. An intestinal 
tonometer (Tonometrics, Bethesda, Md.) was placed into 
the lumen of the distal ileum through the same enterot- 
omy. Tonometers were also guided into the stomach (per 
os) and rectum (per rectum). A 30-minute stabilization 
period was allowed before baseline systemic and splanch- 
nic hemodynamic values and arterial, mixed venous, and 
portal venous blood gas measurements were recorded. 
Beef lung heparin (400 IU/kg, Upjohn, Kalamazoo, 
Mich.) was given for systemic heparinization, followed by 
subsequent administrations to maintain the activated clot- 
ring time (model 400, Hemochron, Edison, N.J.) greater 
than 450 seconds. Normothermic, nonpulsatile, noncross- 
clamped CPB was initiated with two-stage single venous 
cannulation (34F, Bard, Tewksbury, Mass.) and aortic 
arch perfusion (21F, Argyle, St. Louis, Mo.). A membrane 
oxygenator with an integral heat exchanger (Plexus, Ir- 
vine, Calif.), a roller pump (model 5000, 3M/Sarns, Ann 
Arbor, Mich.), and an in-line arterial filter (Pall, Fajardo, 
Puerto Rico) were used in the perfusion circuit (Tygon, 
Akron, Ohio). The CPB circuit was primed with 1000 ml 
Plasmalyte solution (Baxter, Deerfield, Ill.) and 500 ml 
6% hetastarch (Du Pont, Wilmington, Del.). CPB flow 
was maintained at100 ml/kg per minute to keep the mixed 
venous oxygen saturation (Svoz) greater than 70% per the 
protocol. Standard perfusion parameters of Svo» mean 
arterial pressure, central venous pressure, and hematocrit 
were measured at 30, 60, 90, and 120 minutes of CPB. 
Blood flow and gastrointestinal tract mucosal pH mea- 
surements were also recorded at baseline and every 30 
minutes during CPB. No vasoactive drugs or blood were 
used. At the end of the 120-minute bypass period, animals 
were killed with 10 ml intravenous saturated KCI. 
Mean arterial and central venous pressures were mea- 
sured with the use of transducers (P23, Statham Gould, 
Oxnard, Calif.) connected toa multichannel pen recorder 
(model 7758, Hewlett-Packard, Waltham, Mass.). Cardiac 
output was determined by the thermodilution technique 
with a cardiac output computer (Oximetrix 3, Abbott, 
North Chicago, Ill.). Arterial, mixed venous, and mesen- 
teric venous blood gas values were measured with a blood 
gas analyzer and Co-Oximeter (system 1302 and model 
282, Instrumentation Laboratory, Lexington, Mass.) and 
corrected to the animal's temperature. 
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Gut oxygen delivery (Do2) and VO 2 were  determined by 
the following equations: 
Gut Do2 (ml/mtin/m 2) 
[(Sao 2 • 0.134 × Hgb)+ (Pa% × 0.003)] × Qm 
SA 
and 
Gut VO 2 (ml/rnin/m 2)
[(Sao2 - Spo2) x 0.134 x Hgb 
+ (Pao2 - PpQ) x 0.003] x Qm 
SA 
where Sa% and Spo 2 are the arterial and portal blood O2 
saturation (percentage), Pao 2 and Ppo 2 are the arterial 
and portal blood Oz partial pressures (millimeters of 
mereury), Hgb is the hemoglobin coneentration (grams 
per deciliter), Qm is the SMA blood flow (liters per 
minute), and SA is the body surfaee area (square meters). 
Mucosal pH was caleulated on the basis of the mea- 
surement of the CO2 tension (Pco2) from samples of 
saline solution in the silicone balloon eatheters positioned 
in the lumen of the stomach, ileum, and rectum. The 
silicone balloon, which is permeable to CO» is filled with 
saline solution. Because CO2 is a readily diffusible gas, 
PCO 2 of the saline solution in the silieone balloon equili- 
brates witb the intraluminal Pc% of that intestinal seg- 
ment, which, in turn, is in equilibrium with the PCO 2 of the 
mucosa. 1» Samples of the saline solution were allowed to 
equilibrate with the mucosa for 30 minutes, and tono- 
metrically measured Pco2 and the eoncomitantly mea- 
sured arterial [HCO3-] concentration were then substi- 
tuted into the Henderson-Hasselbalch equation to obtain 
the mucosal pH value at baseline and every 30 minutes 
during CPB as follows: 
, [ [HCO3-] ) 
pH = 6.1 + ,Og~pcÖ 2 x-Ö.03) 
where [HCOs-] is the arterial bicarbonate concentration 
(milliequivalents per liter); Pco 2 is that value measured in
the aliquot obtained ffom the tonometer equilibrating 
balloon. 
Blood flow to specific regions of the splanchnic viscera 
was measured by the radioactive microsphere t chnique, is 
Four different isotopes were used in eaeh animal to 
determine fractionated blood flow at different time points. 
Microspheres (15 + 3 /xm diameter) labeled with 141Ce, 
85 95"~ 46 Sr, Nb, and Sc were suspended in 10% dextran with 
polysorbate 80 (Tween 80, DuPont, Boston, Mass.). They 
were injected into the left atrium (at baseline) and arterial 
cannula t 5, 60, and 120 minutes of CPB. Calibration of 
blood flow was done by withdrawing a reference sample 
of aortic blood at 7.5 ml/min starting just before injection 
of the microspheres and continuing for 3 minutes. Ap- 
proximately 4 to 8 × 106 microspheres were injected with 
each measurement. This ensured that at least 400 micro- 
spheres per gram were lodged in most issue samples or in 
the arterial reference for a 95% confidence of an error less 
than 10%. Blood flow to right and left kidneys was 
Table I. The main physiologic variables during CPB 
Minutes of bypass MAP (mm Hg) Svo 2 (%) Hct (%) 
Baseline 77.0 ± 5.5 86.0 ± 2.5 28.4 + 1.5 
30 54.6 ± 7,9" 75.0 +- 2.4# 15.6 + 1.3t 
60 62.3 ± 8,7" 73.8 ± 2.0t 16.8 ± 0.8t 
90 51.9 _+ 5,2" 71.5 ± 2.1t 17.5 --- 0.9t 
120 52.5 --- 6.8* 71.4 ± 2.3t 15.9 --- 0.7t 
MAP, Mean arterial pressure; Hct, hematocrit. 
*p < 0.05 versus baseline value. 
tp < 0.01 versus baseline vatue. 
compared to confirm adequate aortic mixing of micro- 
spheres during injection. 
At autopsy, multiple full-thickness wall tissue samples 
(2 × 2 cm) were taken from stomach, duodenum, jeju- 
num, ileum, and colon. All the tissue samples were placed 
into preweighed polypropylene tubes together with the 
reference blood samples. Individual isotope activities 
were determined by a gamma counter (model A5550, 
Packard, Laguna Hills, Calif.). Blood flow was calculated 
by the following formula and is reported as milliliters per 
minute per 100 grams of tissue: 
Mt × Qref x 100 
QT= 
Mref x Wt 
where Qt is tissue blood flow (milliliters per minute per 
100 grams tissue), Mt is microsphere radioactivity in the 
tissue sample (counts per minute), Qref is the withdrawal 
rate of the aortic reference sample (milliliters per 
minute), Mref is the microsphere radioactivity in refer- 
ence blood samples (counts per minute), and Wt is the 
sample weight (grams). 
Data are expressed as mean plus or minus the standard 
error of the mean and were displayed and analyzed by 
SigmaPlot and SigmaStat programs (Jandel Scientific, San 
Rafael, Calif.). Comparisons with baseline values were 
made by one-way analysis of variance with Dunnett's test, 
with time treated as a repeated measurement factor. 
Significance was accepted with p < 0.05. 
Results 
The main physiologic variables during CPB are 
summarized in Table I. During CPB at a flow rate of 
100 ml/kg per minute, mean arterial pressure was 
maintained higher than 50 mm Hg and Svo 2 higher 
than 70%, as dictated by the experimental protocol. 
The expected hemodilution occurred and the he- 
matocrit value was maintained higher than 15%. 
Changes in overall and mucosal gut perfusion, 
represented by SMA blood flow and ileal mucosal 
blood flow, respectively, are shown in Fig. 1. SMA 
blood flow was 0.48 ___ 0.03 L/min at baseline but 
significantly increased to greater than 130% of 
baseline values during CPB. The nature of laser 
Doppler flowmetry does not lend itself to calibration 
in milliliters per minute and results are only pre- 
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Fig. 1. SMA and ileal mucosal blood flow during CPB. SMA blood flow significantly increased to greater 
than 130% of baseline values, whereas ileal mucosal blood flow significantly decreased toapproximately 
50% of baseline value. *p < 0.05 versus baseline value; **p < 0.01 versus baseline value. 
sented as percent of the baseline value. Despite the 
increase in SMA blood flow, ileal mucosal blood 
flow significantly decreased toapproximately 50% of 
the baseline value during CPB. The decrease in ileal 
mucosal flow during bypass is consistent with the 
significantly decreased Svo2 in the portal venous 
blood during CPB (Fig. 2). 
Changes in the gastrointestinal tract mucosal pH 
during CPB as measured by tonometry are shown in 
Fig. 3. Gastric, ileal, and rectal pH values all de- 
creased significantly from baseline values during 
CPB. 
The pH values of arterial, mixed venous, and 
portal venous blood at baseline and during CPB are 
shown in Fig. 4. Arterial and mixed venous blood 
pH values remained normal during CPB. However, 
portal venous blood pH values decreased signifi- 
cantly from 7.37 at baseline to approximately 7.30 at 
90 and 120 minutes of CPB. 
Changes in blood flow from baseline to the 
splanchnic organs as measured by microspheres are 
presented in Table II. Baseline blood flow to the 
duodenum, jejunum, ileum, and colon was 40.4 _ 
5.9, 47.9 + 13,3, 42.7 _+ 7.9, and 35.4 + 7.2 ml/min 
per 100 grams of tissue, respectively. Blood flow 
significantly increased in the proximal portions of 
the gut, the duodenum and jejunum, during CPB, 
whereas it remained unchanged in the distal por- 
tions, the ileum and colon. 
Fig. 5 shows the relationship of gut Do 2 and Vo2 
during CPB. There was a significant decrease in gut 
Do2 during CPB; however, gut Voz increased pro- 
gressively and independently of the decrease in gut 
Do z. The gut Do2/Vo 2 ratio also decreased progres- 
sively during CPB, but remained greater than 2.9 -+ 
0.3 throughout CPB. 
Discussion 
An in¢rease in mucosal permeability has bcen 
implicated for translo¢adon of ba¢teria nd cndo- 
toxins and subsequently for ¢ontributing to the 
systemi¢ inflammatory esponse syndrome and mul- 
tiorgan dysfun¢tion syndrome in patients undergo- 
ing CPB. 8 The intestinal mu¢osal barrier consists of 
mu¢oid se¢rctions and proliferative pithelial cells 
with tight inter¢ellular jun¢tions. The barrier is 
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Fig. 2. Changes in portal blood 02 saturation during CPB. Consistent with decrease in mucosal blood 
flow, portal blood 02 saturation significantly decreased during CPB. *p < 0.05 versus baseline value. 
characterized byits relative impermeability to most 
solutes and active transport mechanisms of selected 
ones. 19 This barrier, along with other functions, 
prevents bacteria nd their endotoxins from enter- 
ing the portal and systemic irculation. 
Our earlier 11' 12 and present studies have shown 
that normothermic CPB is associated with gut mu- 
cosal ischemia despite "adequate" global perfusion: 
there is normal or even increased overall blood flow 
through the SMA, but the gut mucosa remains 
ischemic, as evidenced by mucosal blood hypoper- 
fusion measured by laser flowmetry and mucosal 
acidosis measured by tonometry. Coinciding with 
this observation are results of clinical studies that 
show similar evidence of gut mucosal ischemia 
during CPB. Fiddian-Green and Baker, 15 using the 
orogastric tonometer, reported a50% prevalence of 
mucosal acidosis as manifested by a decrease in 
gastric mucosal pH values from 7.52 before CPB to 
less than 7.32 by the end of CPB in 85 patients. 
Andersen and associates 2° found that the gastric 
mucosal pH in 10 patients decreased from 7.45 
before CPB to 7.30 at 1 hour after CPB. In a series 
of eight patients, Niinikoski and Kuttila 21 showed 
that the gastric pH decreased progressively during 
cardiac operation and remained low after operation. 
In 10 patients undergoing coronary artery bypass 
grafting Ohri and associates 14 measured a 51% 
decrease in gastric mucosal blood flow with the use 
of laser Doppler flowmetry, a finding similar to our 
experimental data. Although gut mucosal ischemia 
during CPB is demonstrated in immature swine in 
our studies, the trend to or severity of mucosal 
ischemia nd acidosis in adult patients undergoing 
cardiac operations in the studies cited is similar. 
Our present study demonstrates that mucosal 
ischemia during normothermic CPB results from the 
combination of mucosal hypoperfusion and in- 
creased gut Vo 2. With the measured increäse in 
overall gut blood flow, mucosal hypoperfusion is 
likely to be the result of mucosal vasoconstriction 
and blood redistribution away from the mucosa. A
host of vasoactive substances (hormones, autacoids, 
and cytokines) are known to be released or altered 
during CPB that can potentially affect regional 
blood flow at the macrocirculatory and microcircu- 
latory levels, 22 and these substances can also be 
candidates for vasoconstriction f gut mucosa. Main 
vasoconstrictors that have been shown to be re- 
leased during CPB include vasopressin, 23 cat- 
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Fig. 3. Gut mucosal pH values during CPB. Gastric, rectai, and ileal mucosal pH values all decreased 
significantly during CPB. *p < 0.05 versus baseline value. 
echolamines, 24 and thromboxane Az and B2 .25' 26 In 
a model of experimental CPB identical to that of the 
current study, out group found elevated levels of a 
highly vasoconstrictive thromboxane compound in 
association with the decrease in mucosal blood 
flow. 11 CPB in human beings is associated with an 
increase in circulating tumor necrosis factor forma- 
tion that can activate other vasoactive substances. 7 
Initiation of CPB is also associated with activation of 
complement (C3a and C5a), 27 which causes vaso- 
constriction and increased capillary permeability. 2s 
Loss of pulsatility in the renal arteries and low 
perfusion can trigger the renin-angiotensin-aldoste- 
rone system and lead to increased production of 
angiotensin II,29' 3o which is also a potent splanchnic 
vasoconstrictor. Antagonists of such vasoconstric- 
tive mediators and the effect of pulsatile blood flow 
during CPB on mucosal perfusion, therefore, war- 
rant further studies. 
Increased gut Vo2 was another contributing factor 
to mucosal ischemia in out study. During normo- 
thermic CPB, gut Vo2 progressively increased e- 
spite the decrease in gut Do z. Increased total body 
V02 and a higher metabolic rate have been shown in 
patients after cardiac operations. 31-34 Such changes 
in VO 2 may be a result of inflammatory esponses 
initiated uring CPB. Hypothermia, however, may 
diminish this response. Indeed, during experimental 
hypothermic CPB, 13 gut Vo2 initially decreased 
when the animal was cooled, but surged to 33% 
higher than the baseline value during rewarming. 
Studies on the Do2-Vo 2 relationship have shown 
that Vo2 is independent of Do 2 as long as the 
Do2/Vo 2 ratio is higher than a critical value, below 
which anaerobic metabolism occurs and Vo 2 de- 
creases concomitantly with Do2 .35' 36 Measurements 
of Do2 and Vo2 with instrumentation similar to that 
used in the present study suggested that the critical 
value of the Doa/Vo 2 ratio is approximately 1.3 for 
the whole body and 1.5 for the gut, and these ratios 
increased to 1.9 and 2.2, respectively, during exper- 
imental sepsis. 37 Sepsis also increases total body and 
gut Vo  2 itself. 37' 38 During CPB, the abrupt decrease 
in Oz delivery because of hemodilution coupled with 
increased oxygen demand could result in pathologic 
oxygen supply dependency that will limit the in- 
crease in Vo2 .39 In our model of normothermic 
bypass, the gut Do2/Vo 2 ratio remained greater than 
2.9 and Vo2 increased progressively throughout the 
co urse of CPB, suggesting high gut metabolism, 
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Fig. 4. Arterial, mixed venous, and portal venous blood pH values during CPB. Although arterial and 
mixed venous blood pH values remained relatively normal throughout CPB, portal venous blood pH value 
decreased significantly at90 and 120 minutes of bypass. *p < 0.05 versus baseline value. 
probably as a result of an inflammatory esponse. 
Such inflammatory esponses and their effect on the 
gut Do2-Vo 2 relationship during CPB remain to be 
further defined. In addition, hypothermic CPB, with 
its effect on reducing the oxygen demand of the gut 
tissue, may partially protect he gut from mucosal 
ischemia. 
The gut lumen is a rich source of gram-negative 
bacteria that constantly release lipopolysaccharide 
from their outer membrane; these endotoxins nor- 
mally cannot cross the mucosal barrier because of 
their relatively large molecular size. Even if some 
small amounts cross, they are efficiently scavenged 
by the reticuloendothelial system. Mucosal ischemia 
occurring during CPB may greatly increase mucosal 
permeability. 14'4° Increased mucosal permeability, 
along with a known dysfunction of the hepatic 
reticuloendothelial system 41 and the systemic immu- 
nosuppression 42 associated with CPB, may allow 
bacteria nd particularly smaller endotoxins to enter 
the portal and systemic irculation. In turn, bacte- 
remia or endotoxemia, or both, exacerbate mucosal 
ischemia nd promote translocation 43'44 and further 
increase the metabolic demand for oxygen in 
Table II. Blood flow to the gut measured by 
microspheres (percent of baseline) 
Minutes 
of CPB Duodenum ]ejunum Ileum CoIon 
5 150_+13" 131_+10" 113 +14 107_+14 
60 148_+14" 108_+16 89+12 101_+11 
120 127_+12" 129_+15" 102_+10 106_+10 
*p < 0.05 versus baseline value. 
splanchnic organs. 45 This hypothesis  supported by 
the fact that endotoxin levels during CPB are pref- 
erentially higher in the blood of the splanchnic 
circulation, 2° and the degree of mucosal acidosis 
during CPB correlates well with the risk for subse- 
quent complications or death. 46 
In summary, the present study demonstrates sig- 
nificant gut mucosal ischemia during normothermic 
CPB despite normal indices of global perfusion. 
Factors that contribute to mucosal ischemia include 
redistribution ofblood flow away from the mucosa, 
possibly because of regional vasoconstriction, and 
increased total gut metabolism. Gut mucosal isch- 
emia during CPB may lead to mucosal barrier 
malfunction and translocation of bacteria or endo- 
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Fig. 5. Changes in gut DO 2 and Vo 2 during CPB. Gut DO 2 significantly decreased during CPB, but gut Vo2 
increased progressively and independently of the decrease in gut Do2. Gut Do2/Vo2 ratio decreased 
progressively during CPB, but remained greater than 2.9. *p < 0.05 versus baseline value. 
toxins, or both, causing postperfusion systemic in- 
flammatory response syndrome and multiorgan dys- 
function syndrome. Strategies to effectively reduce 
redistribution of intestinal blood flow during CPB 
may decrease the resultant morbidity and mortality 
in patients at high risk. 
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